Amphetamine increases the activity of several chemical messengers in your brain, most notably dopamine and norepinephrine. This surge affects everything from focus and motivation to heart rate and appetite. At prescribed doses, amphetamine is used to treat ADHD and narcolepsy. At higher or non-prescribed doses, it carries serious risks for the brain and cardiovascular system.
How Amphetamine Works in the Brain
Your brain cells communicate by releasing chemical messengers (neurotransmitters) into the gaps between them. Normally, after a neurotransmitter like dopamine does its job, it gets pulled back into the cell that released it and stored in tiny compartments for later use. Amphetamine disrupts this cycle at multiple points.
First, amphetamine enters nerve cells and blocks the storage compartments that hold dopamine and norepinephrine, forcing those chemicals to spill out into the cell body. At the same time, it activates an internal receptor that flips the direction of the transporter proteins sitting on the cell’s surface. Instead of pulling dopamine back in, these transporters start pumping it out. The net result is a flood of dopamine and norepinephrine into the spaces between brain cells, where they amplify signaling related to reward, attention, and arousal.
This is fundamentally different from how caffeine or most antidepressants work. Rather than simply blocking reuptake or mimicking a neurotransmitter, amphetamine actively forces extra release. That’s why its effects are so pronounced and why the potential for misuse is significant.
Effects on Focus and Motivation
In people with ADHD, the dopamine and norepinephrine systems are underactive in ways that make it harder to sustain attention, resist distractions, and push through tasks that feel boring or effortful. Amphetamine corrects this imbalance rather than creating a new one.
Research from the National Institutes of Health found that people with ADHD are measurably more sensitive to effort, both cognitive and physical. They find tasks that require sustained concentration more aversive than people without ADHD do. Amphetamine treatment mostly restored their willingness to invest effort to levels similar to healthy controls, and this effect applied uniformly across mental and physical tasks. In other words, the drug doesn’t just sharpen attention. It makes effortful work feel less punishing, which is often what people with ADHD describe when they say the medication “helps them focus.”
The improvements are clinically significant. On standardized rating scales, untreated adults with ADHD score around 75 to 81 on measures of inattention (compared to roughly 47 to 49 for people without ADHD). Amphetamine narrows that gap substantially, though it doesn’t eliminate it entirely.
Physical Effects on the Body
Because amphetamine also boosts norepinephrine, which governs the body’s fight-or-flight response, it has measurable cardiovascular effects even at standard doses. A large meta-analysis covering more than 10,000 participants found that therapeutic doses raise systolic blood pressure by about 2 mmHg, diastolic blood pressure by about 2 mmHg, and heart rate by roughly 4 beats per minute. For most healthy people, these are small, clinically insignificant changes. For someone with existing heart disease or uncontrolled high blood pressure, they can be dangerous.
Amphetamine also suppresses appetite and delays sleep onset, which are among the most commonly reported side effects. In clinical trials of the extended-release formulation, appetite loss affected 33% of adults (versus 3% on placebo), insomnia affected 27% (versus 13% on placebo), and dry mouth affected 35% (versus 5% on placebo). Adolescents experienced even higher rates of appetite suppression, at 36%. These effects tend to be most noticeable in the first weeks of treatment and may lessen over time, though appetite suppression often persists.
How Long It Lasts
Amphetamine is actually a mix of two mirror-image molecules that your body processes at different speeds. The more potent form, d-amphetamine, has an average half-life of 10 hours in adults. The other form, l-amphetamine, lingers longer at around 13 hours. A half-life is the time it takes for half the drug to leave your system, so it takes roughly two to three half-lives before the effects fully wear off.
In children aged 6 to 12, both forms clear slightly faster, with half-lives of about 9 and 11 hours respectively. This is why children sometimes need dosing adjustments or may notice effects wearing off before the school day ends. Extended-release formulations are designed to stagger the release of the drug over many hours, smoothing out the peaks and troughs that come with immediate-release versions.
What Happens With Long-Term or Heavy Use
Decades of research using brain imaging and animal models show that chronic, heavy amphetamine or methamphetamine use produces lasting changes in the dopamine system. The most consistent finding is a reduction in the availability of certain dopamine receptors in the brain’s reward centers. Essentially, the system that registers pleasure and motivation becomes blunted. This is one reason why people who misuse stimulants over long periods often describe feeling flat, unmotivated, or unable to enjoy things without the drug.
These changes also affect synaptic plasticity, the brain’s ability to strengthen or weaken connections based on experience. Altered plasticity in reward circuits helps explain why cravings can intensify over time even after someone stops using. Animal studies show that craving for methamphetamine actually increases during abstinence, a phenomenon researchers call “incubation of craving,” driven by changes in how certain receptor signals are processed in the brain’s reward hub.
It’s worth noting that most of this research involves doses and patterns far exceeding therapeutic use. The neurological consequences of taking a prescribed dose for ADHD are not equivalent to those seen in chronic misuse, though the underlying mechanisms overlap.
Withdrawal After Stopping
Withdrawal symptoms typically appear within 24 hours of the last dose and unfold in two phases. The first is an acute “crash” lasting about a week, characterized by intense fatigue, low mood, irritability, anxiety, increased appetite, and strong cravings. Many people also experience excessive sleep or vivid, unpleasant dreams during this phase.
The second phase is subtler but longer. A set of lingering symptoms, including depressed mood, difficulty concentrating, and fluctuating energy, generally resolves over three weeks, though some people report effects lasting longer. The severity of withdrawal depends heavily on how much and how long someone was using. People discontinuing a low therapeutic dose may notice mild fatigue and mood dips for a few days. People coming off prolonged heavy use can experience weeks of significant depression and paranoia.
Who Should Not Take Amphetamine
Amphetamine is contraindicated for people with several specific conditions. These include advanced hardening of the arteries, structural heart abnormalities (such as cardiomyopathy or certain valve defects), serious arrhythmias, coronary artery disease, moderate to severe hypertension, and uncompensated heart failure. People with an overactive thyroid are also excluded because the combination can dangerously amplify cardiovascular strain.
Narrow-angle glaucoma is another contraindication. Amphetamine dilates the pupils, which can increase pressure inside the eye and trigger an acute glaucoma episode in people with anatomically narrow drainage angles. People with significant anxiety or agitation may also find that amphetamine worsens these symptoms, since the same norepinephrine surge that improves focus in one person can feel like panic in another.